Youn-HeeKimMD

Dermatology • Stanford, CA

Professor, Dermatology, Stanford University School of Medicine

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 1985 - 1989
Kaiser Permanente Northern California (San Francisco)Internship, Internal Medicine, 1984 - 1985
Stanford University School of MedicineClass of 1984

Certifications & Licensure

CA State Medical License 1986 - 2025
American Board of Dermatology Dermatology

Publications & Presentations

PubMed

10 citations
Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative D...
Joan Guitart, Aaron R Mangold, Maria Estela Martinez-Escala, Christina J Walker, Nneka I Comfere
JAMA Dermatology. 2022-10-01
6 citations
What factors guide treatment selection in mycosis fungoides and Sezary syndrome?
Youn H Kim
Hematology. American Society of Hematology. Education Program. 2021-12-10
71 citations
Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC.
Elise A. Olsen, Sean Whittaker, Rein Willemze, Lauren C. Pinter-Brown, Francine M. Foss
Blood. 2021-11-10

Journal Articles

Targeted Killing of TNFR2-Expressing Tumor Cells and Tregs by TNFR2 Antagonistic Antibodies in Advanced Sézary Syndrome
D L Faustman, Y H Kim, M Khodadoust, Nature

Abstracts/Posters

A Phase 1/1b Dose-Escalation Trial Evaluating Cpi-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, in Subjects with Relapsed/Refractory T-Cell Lymphoma
Youn H. Kim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019